The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Am J Psychiatry 163:1202-1207, July 2006
doi: 10.1176/appi.ajp.163.7.1202
© 2006 American Psychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Jang, J. H.
* Articles by Kim, S. I.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Jang, J. H.
* Articles by Kim, S. I.
Related Collections
* Obsessive-Compulsive Disorder
* MRS

A Proton MRSI Study of Brain N-Acetylaspartate Level After 12 Weeks of Citalopram Treatment in Drug-Naive Patients With Obsessive-Compulsive Disorder

Joon Hwan Jang, M.D., Jun Soo Kwon, M.D., Ph.D., Dong Pyo Jang, Ph.D., Won-Jin Moon, M.D., Ph.D., Jong-Min Lee, Ph.D., Tae Hyun Ha, M.D., Eun Chul Chung, M.D., Ph.D., In Young Kim, M.D., Ph.D., and Sun I. Kim, Ph.D.

OBJECTIVE: Reductions in the level of N-acetylaspartate within subcortical structures of patients with obsessive-compulsive disorder (OCD) have been reported in several studies. However, there have been, as yet, no reports regarding N-acetylaspartate levels in the prefrontal cortex of adult drug-naive OCD patients. The authors used proton magnetic resonance spectroscopic imaging (1H-MRSI) to investigate regional N-acetylaspartate level abnormalities and changes after 12 weeks of pharmacotherapy with citalopram in drug-naive OCD patients. METHOD: Thirteen drug-naive OCD patients and 13 age- and sex-matched healthy comparison subjects were included in this study. N-acetylaspartate levels (obtained from ratios of N-acetylaspartate with creatine, choline, and creatine plus choline) in the prefrontal cortex, parietal cortex, anterior cingulate, posterior cingulate, frontal white matter, and parietal white matter were measured by 1H-MRSI. In OCD patients, measurements were taken before and after 12 weeks of citalopram treatment. Correlations between N-acetylaspartate concentrations in regions of interest and clinical measures were also assessed. RESULTS: Drug-naive OCD patients exhibited significantly lower N-acetylaspartate levels in the prefrontal cortex, frontal white matter, and anterior cingulate at baseline than did comparison subjects. Significant increases in N-acetylaspartate level were detected in the prefrontal cortex and frontal white matter in OCD patients after 12 weeks of citalopram treatment. CONCLUSIONS: These data suggest that reductions in neuronal viability occur in the frontal region of OCD patients and that these reductions may be partly reversible.




This article has been cited by other articles:


Home page
Arch Gen PsychiatryHome page
M. Yucel, B. J. Harrison, S. J. Wood, A. Fornito, R. M. Wellard, J. Pujol, K. Clarke, M. L. Phillips, M. Kyrios, D. Velakoulis, et al.
Functional and Biochemical Alterations of the Medial Frontal Cortex in Obsessive-Compulsive Disorder
Arch Gen Psychiatry, August 1, 2007; 64(8): 946 - 955.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2006 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org